Clinical Conductor CTMS?s parent company, Bio-Optronics, Inc., and the Society of Clinical Research Sites (SCRS) have collaborated to expand and advance the knowledge of clinical trial site management challenges and opportunities.
Clinical Conductor CTMS’s parent company, Bio-Optronics, Inc., and the Society of Clinical Research Sites (SCRS) have collaborated to expand and advance the knowledge of clinical trial site management challenges and opportunities. Through this relationship, Clinical Conductor CTMS and the SCRS have identified critical metrics with the aim of establishing industry benchmarks for clinical research sites.
“SCRS is committed to supporting the success of the global clinical site community. Reliable data and metrics provide sites and industry stakeholders with information that will help shape the site landscape,” says Christine Pierre, President of SCRS. “The collaboration with Clinical Conductor CTMS during these early stages has been instrumental in helping us achieve this goal. Their willingness to collaborate with SCRS and to build SCRS’ Site Metrics Platform to allow all sites to contribute their data moving forward is a testimonial to the collaborative efforts SCRS values.”
Clinical Conductor CTMS has provided the SCRS with de-identified, non-patient information from sites who have agreed to participate. Site metrics provided from Clinical Conductor CTMS will assist SCRS to establish site metrics and cycle times for a number of clinical trial parameters. This information includes study startup cycle time, patient enrollment metrics, budgetary and contract statistics and other analytics.
“The advancement of clinical trial management and research operations is one of the guiding principles behind Clinical Conductor CTMS,” explains Dan Kerpelman, CEO of Bio-Optronics. “Working with the SCRS to establish actionable metrics for the benefit of all researchers was a natural initiative for our organization. We take pride in our ability to participate in this noteworthy and beneficial venture.”
The SCRS and Clinical Conductor CTMS collaboration is intended to be an ongoing endeavor and will continue to expand and enhance the industry benchmark initiative that is being established. The initial results include Clinical Conductor CTMS sites that have chosen to participate in this endeavor. However, the SCRS benchmarking engine, built by Clinical Conductor CTMS, has been designed to allow research sites using other CTMS applications to include their data and benefit from future benchmarking reports. The initial results of this collaboration will be unveiled during the “Benchmarking Your Site” session at the Site Solutions Summit in Amelia Island, FL on October 12, 2013.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.